National Law Firm, Arentz Law Group, Seeks Justice for Zofran Birth Defect Victims

By: PRLog
Drugmaker GlaxoSmithKline stands accused of promoting and marketing use of Zofan to pregnant women without informing them of the potential risks.
PRLog - April 27, 2015 - PHOENIX -- The nationally recognized attorneys of Arentz Law Group, P.C. are currently reviewing cases of individuals who suffered injury, harm, or the wrongful death of a loved one due to Zofran side effects. The anti-nausea medication Zofran, approved by the FDA for the treatment of cancer and surgical patients, has routinely been prescribed off-label to pregnant women seeking relief from morning sickness. Drugmaker GlaxoSmithKline is accused of promoting and marketing use to pregnant women despite the company never having investigated the safety of such use.

Before generic formulations became available in 2006, prescriptions for Zofran were making $1.3 billion in sales for GlaxoSmithKline. It is estimated that nearly a quarter of all prescriptions at that time were written by doctors caring for pregnant patients. However, several independent studies were conducted worldwide which have linked use of the medication by pregnant women to a significantly higher incidence of a variety of birth defects among newborns. Lawsuits filed on behalf of such children claim the drug is responsible for numerous heart defects, cleft palates, and many other abnormal physical developmental disorders.

If you or a loved one have taken Zofran or Ondansetron while pregnant, and have a child now suffering from birth defects you may be entitled to compensation. The attorneys of Arentz Law Goup are offering free case evaluations for Zofran Victims. Arentz Law Group can be reached for free Zofran case evaluations by calling 1-800-305-6000.

Arentz Law Group Zofran video clip: https://youtu.be/X2CDnnYzU84

Read Full Story - National Law Firm, Arentz Law Group, Seeks Justice for Zofran Birth Defect Victims | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.